The Link Between Testosterone and Cardiovascular Health: What You Need to Know

Written by Adam Maggio | Medically reviewed by Dr. Mitchell Ross, MD, ABAARM

Testosterone impacts cardiovascular health by influencing cholesterol, blood pressure, and vascular function. Balancing levels is key to reducing heart disease risk.

# The Link Between Testosterone and Cardiovascular Health

Testosterone is widely recognized as the primary male sex hormone, essential for reproductive health and the development of male characteristics. Beyond these roles, testosterone also impacts various physiological systems, including cardiovascular health. Recent research highlights a complex relationship between testosterone levels and cardiovascular risk, with implications for both men and women. Understanding this connection is critical for clinicians and patients considering testosterone therapy or managing cardiovascular disease (CVD).

Testosterone: An Overview

Testosterone is produced mainly in the testes in men and in smaller amounts by the ovaries and adrenal glands in women. It influences muscle mass, bone density, fat distribution, mood, and energy levels. Testosterone levels naturally decline with age, often leading to symptoms like fatigue, decreased libido, and loss of muscle strength.

Normal total testosterone levels typically range from:

  • Men: 300–1,000 ng/dL
  • Women: 15–70 ng/dL

    • Low testosterone (hypogonadism) can result from aging, chronic illness, or endocrine disorders.

    Cardiovascular Disease and Testosterone: The Complex Relationship

    Cardiovascular disease remains the leading cause of morbidity and mortality worldwide. Common risk factors include hypertension, dyslipidemia, diabetes, obesity, and lifestyle factors such as smoking and sedentary habits.

    Low Testosterone and Cardiovascular Risk

    Several epidemiological studies show that men with low testosterone levels have a higher prevalence of cardiovascular risk factors and adverse events, including:

  • Increased atherosclerosis
  • Higher incidence of coronary artery disease (CAD)
  • Greater mortality from cardiovascular causes

    • For example, a large meta-analysis published in the European Heart Journal (2011) reviewed data from multiple cohort studies and found that low testosterone predicted cardiovascular events and all-cause mortality independently of age and traditional risk factors.

    Possible mechanisms include:

  • Altered lipid metabolism: Low testosterone is associated with increased LDL cholesterol and triglycerides and lower HDL cholesterol.
  • Insulin resistance: Testosterone deficiency correlates with impaired glucose metabolism and type 2 diabetes, both major cardiovascular risk factors.
  • Endothelial dysfunction: Testosterone influences nitric oxide production, important for vascular health. Deficiency may impair vasodilation and promote inflammation.
  • Body composition: Low testosterone promotes visceral fat accumulation, a known cardiovascular risk factor.

    • High Testosterone and Cardiovascular Risk

    Conversely, supraphysiologic testosterone levels, especially from anabolic steroid abuse, have been linked to adverse cardiovascular outcomes, such as:

  • Hypertension
  • Left ventricular hypertrophy
  • Arrhythmias
  • Increased thrombotic events

    • However, testosterone replacement therapy (TRT) aiming to restore physiological levels generally does not carry these risks when properly monitored.

    Testosterone Replacement Therapy and Cardiovascular Health

    TRT is prescribed to men with clinically significant hypogonadism to alleviate symptoms and restore testosterone to normal ranges. Common formulations include:

  • Intramuscular injections (e.g., testosterone enanthate or cypionate)
  • Transdermal gels or patches
  • Buccal tablets
  • Subcutaneous pellets

    • Dosing Guidelines

  • Typical starting dose for intramuscular injections: 50–100 mg weekly or 100–200 mg every 2 weeks.
  • Transdermal gels: usually 5–10 g daily delivering 50–100 mg testosterone.

    • Dosing is individualized based on serum testosterone measurements and clinical response.

    Cardiovascular Effects of TRT

    The impact of TRT on cardiovascular health has been controversial. Some randomized controlled trials and meta-analyses suggest:

  • Potential benefits: Improved insulin sensitivity, reduced fat mass, better lipid profiles, and improved endothelial function.
  • Concerns: Increased hematocrit, potential for fluid retention, and theoretical risk of thrombosis.

    • A 2018 systematic review in the Journal of Clinical Endocrinology & Metabolism concluded that TRT in men with low testosterone levels does not increase cardiovascular risk and may improve certain risk factors, but emphasized the need for more large-scale long-term studies.

    Clinical Protocol and Monitoring

    Men receiving TRT should be carefully evaluated before and during therapy:

  • Baseline cardiovascular risk assessment (blood pressure, lipid profile, glucose)
  • Measurement of hematocrit and hemoglobin before initiation and regularly thereafter
  • Monitoring testosterone levels to maintain physiological range
  • Regular follow-up (every 3–6 months) to assess symptoms and adverse effects

    • Patients with uncontrolled cardiovascular disease require careful consideration and close supervision if TRT is initiated.

    Special Considerations in Women

    Testosterone is also present in women at low levels, and its role in female cardiovascular health is less well established. Some studies suggest low testosterone levels in postmenopausal women correlate with increased cardiovascular risk, but more research is needed.

    Practical Recommendations

  • Identify low testosterone: Symptoms combined with biochemical confirmation are needed before considering therapy.
  • Assess cardiovascular risk: Evaluate traditional risk factors alongside testosterone status.
  • Consider TRT cautiously: Indicated primarily for symptomatic men with low levels and hypogonadism.
  • Monitor regularly: Ensure testosterone levels, hematocrit, and cardiovascular markers remain in safe ranges.
  • Lifestyle modifications: Exercise, diet, and smoking cessation are essential adjuncts for cardiovascular health.

    • Most importantly, individuals should consult their healthcare provider before initiating testosterone therapy or making decisions based on testosterone levels.

    Conclusion

    Testosterone plays a nuanced role in cardiovascular health. Low testosterone levels are associated with increased cardiovascular risk factors and adverse outcomes. Testosterone replacement therapy, when administered appropriately, may improve cardiovascular parameters and quality of life in men with hypogonadism, but requires careful monitoring to minimize risks.

    Ongoing research continues to clarify testosterone’s cardiovascular effects, emphasizing that therapy should be personalized and integrated into comprehensive cardiovascular risk management.

    ---

    References:

  • Fernández-Balsells MM, et al. Clinical Review: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010;95(6):2560-2575.
  • Malkin CJ, et al. Low serum testosterone and increased mortality in men with coronary heart disease. Heart. 2010;96(22):1821-1825.
  • Saad F, et al. Testosterone as potential effective therapy in treatment of metabolic syndrome. Asian J Androl. 2012;14(4):423-433.

    • ---

    If you are experiencing symptoms of low testosterone or have concerns about your cardiovascular health, please consult a qualified healthcare provider for appropriate testing and treatment guidance.